Barbara E Thalenfeld - VP, Enzo Biochem Inc
As of October 19, 2006
Barbara E Thalenfeld Net Worth
- Net worth is estimated to be at least $463.78K
- Owns at least 14,876 units of Enzo Biochem Inc stock
- Sold an estimated value of $142.3K in the last 2 years at Enzo Biochem Inc
Barbara E Thalenfeld Trading
- Largest purchase of shares was 3,350 units , worth over $24.69K on August 16, 2004
- Largest sale of shares was 3,570 units , worth over $63.55K on July 12, 2005
- In total has made about 9 transactions over 2 years
- Usually trades in October and April, with the busiest year in 2004 and 2005
Barbara Thalenfeld
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Barbara E Thalenfeld Mailing Address
- Mailing address is 527 Madison Avenue New York NY 10022 NY
Enzo Biochem Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Elazar Rabbani, Ph.D. | 2020 | $611,000 | $112,400 | $69,740 | $500,000 | $194,661 | $1,487,801 |
| Elazar Rabbani, Ph.D. | 2019 | $611,000 | $135,296 | $70,000 | $500,000 | $190,308 | $1,506,604 |
| Barry W. Weiner | 2020 | $542,000 | $101,000 | $55,600 | $375,000 | $177,949 | $1,251,607 |
| Barry W. Weiner | 2019 | $542,000 | $121,555 | $56,000 | $375,000 | $173,822 | $1,268,377 |
| David Bench | 2020 | $138,462 | $49,000 | $33,000 | $75,000 | $208 | $295,670 |
| David Bench | 2019 | - | - | - | - | - | - |
| Dieter Schapfel, M.D. | 2020 | $330,000 | $49,000 | $29,260 | $60,000 | $13,532 | $481,792 |
| Dieter Schapfel, M.D. | 2019 | $330,000 | $56,316 | $29,400 | $60,000 | $13,282 | $488,998 |
| Kara Cannon | 2020 | $220,000 | $49,000 | $29,260 | $60,000 | $13,052 | $371,312 |
| Kara Cannon | 2019 | $220,000 | $56,316 | $29,400 | $60,000 | $12,802 | $378,518 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/316253/000121390020039593/ea130551-def14a_enzobiochem.htm
Enzo Biochem Inc Insider Trading
- The most recent transaction was 444,768 units sold on March 17, 2021 by Harbert Management Corp, Harbert Discovery Fund Lp, Harbert Discovery Fund GP Llc, Harbert Discovery Coinvestment Fund I Lp, Harbert Discovery Coinvestment Fund I GP Llc, Harbert Fund Advisors Inc, John Bryant, Kenan Lucas and Raymond Harbert worth over $2.09M
- In the last 18 years, insiders at Enzo Biochem Inc sold an estimated value of $19.47M and bought an estimated value of $14.72M
- The most active traders are Barry W Weiner, PRESIDENT AND TREASURER, Elazar Rabbani, CHIEF EXECUTIVE OFFICER, and David C Goldberg, VP CorpDev IGM Enz Clin Labs
- Insider trading is most common in January, with the busiest year in 2004
ENZO BIOCHEM INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||